Creating an evidence map of the safety profile of spironolactone across all clinical indications to establish whether it may be a safe treatment in female adolescent acne: a protocol for a scoping review
Introduction Spironolactone is a useful and effective acne treatment option for adult female patients. We aim to establish whether spironolactone could be a safe treatment for the management of acne in the female adolescent population as well. The objective of this scoping review is to provide an e...
Saved in:
| Main Authors: | Esther Burden-Teh, Myranda Attard, James Law, Zahra Moledina, Susannah George, Fiona C Sexton, Lisa O’Higgins, Julia Fordham, Grishma Ramesh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/8/e106758.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology
by: Soma Khasrow Abdullah, et al.
Published: (2024-09-01) -
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
by: Ingrid Muller, et al.
Published: (2023-12-01) -
The efficacy of Topical Clascoterone versus systematic spironolactone for treatment of acne vulgaris: A systematic review and network meta-analysis.
by: Mohammad A Basendwh, et al.
Published: (2024-01-01) -
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants
by: Amira Soliman, et al.
Published: (2025-03-01) -
Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss
by: Rachel C Hill, et al.
Published: (2025-07-01)